Enhanced turnover of all-trans-retinoic acid and increased formation of polar metabolites in head and neck squamous cell carcinoma lines compared with normal oral keratinocytes

Clinical Cancer Research

Volumn 7, Issue 4, 2001, Pages 1017-1025

  Klaassen, Ingeborg ^a   Brakenhoff, Ruud H ^a   Smeets, Serge J ^a   Snow, Gordon B ^a   Braakhuis, Boudewijn J M ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

18 HYDROXYRETINOIC ACID; 4 HYDROXYRETINOIC ACID; 4 OXOISOTRETINOIN; 4 OXORETINOIC ACID; 5,6 EPOXYRETINOIC ACID; CYTOCHROME P450 26A1; CYTOCHROME P450 ISOENZYME; ISOTRETINOIN; OXYGENASE; RETINAL; RETINOIC ACID; RETINOIC ACID DERIVATIVE; RETINOL; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL METABOLISM; CONTROLLED STUDY; DRUG METABOLISM; GROWTH INHIBITION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CYTOCHROME P-450 ENZYME SYSTEM; HEAD AND NECK NEOPLASMS; HUMANS; KERATINOCYTES; MIXED FUNCTION OXYGENASES; MOUTH; RNA, MESSENGER; TRANSFECTION; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0034910254     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells
2. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia
3. Epidemiology of retinoids and cancer
4. Retinoids in cancer chemoprevention
5. Retinoids and cancer in experimental animals
6. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck
7. Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: A Phase II randomized trial
8. Retinoid chemoprevention of aerodigestive cancer: From basic research to the clinic
9. Follow-up in patients treated for head and neck cancer: How frequent, how thorough and for how long?
10. Retinoids AND human cancer
11. Lipid hydroperoxides greatly increase the rate of oxidative catabolism of all-trans-retinoic acid by human cell culture microsomes genetically enriched in specified cytochrome P-450 isoforms
12. CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family
13. cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450
14. Retinoic acid receptors regulate expression of retinoic acid 4-hydroxylase that specifically inactivates all-trans retinoic acid in human keratinocyte HaCaT cells
15. Cytochrome P450, CYP26AI, is expressed at low levels in human epidermal keratinocytes and is not retinoic acid-inducible
16. Metabolism of all-trans-retinoic acid by cultured human epidermal keratinocytes
17. Metabolism of all-trans-retinol in normal human cell strains and squamous cell carcinoma (SCC) lines from the oral cavity and skin: Reduced esterification of retinol in SCC lines
18. Considerations for in vitro retinoid experiments: Importance of protein interaction
19. A simple and reliable technique for culturing of human oral keratinocytes and fibroblasts
20. Cell surface antigen expression and prognosis
21. Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma
22. Relationship between the parameters cellular differentiation, doubling time and platinum accumulation and cisplatin sensitivity in a panel of head and neck cancer cell lines
23. Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10- deazaaminopterin against human head and neck squamous cell carcinoma
24. Simultaneous analysis of retinol, all-trans- and 13-cis-retinoic acid and 13-cis-4-oxoretinoic acid in plasma by liquid chromatography using on-column concentration after single-phase fluid extraction
25. Identification and quantitation of all-trans- and 13-cis-retinoic acid and 13-cis-4-oxoretinoic acid in human plasma
26. Analytical methods
27. Extraction, purification, and analysis of messenger RNA from eukaryotic cells
28. Metabolism of retinoic acid and retinol by intact cells and cell extracts
29. All-trans-retinoic acid 4-hydroxylation in human liver microsomes: In vitro modulation by therapeutic retinoids
30. Retinol and retinoic acid metabolism
31. 3H]retinoic acid delivered to human foreskin keratinocytes either bound to serum albumin or added directly to the culture medium
32. Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell lines
33. Autoinduction of retinoic acid metabolism to polar derivatives with decreased biological activity in retinoic acid-sensitive, but not in retinoic acid-resistant human breast cancer cells
34. Retinoic acid metabolism and inhibition of cell proliferation: An unexpected liaison
35. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor
36. Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid
37. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid
38. Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells
39. Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells
40. Cytochrome P450RAI(CYP26) promoter: A distinct composite retinoic acid response element underlies the complex regulation of retinoic acid metabolism
41. Retinoic acid receptor γ1 expression determines retinoid sensitivity in pancreatic carcinoma cells
42. Implication of retinoic acid receptor γ in squamous differentiation and response to retinoic acid in head and neck SqCC/Y1 squamous carcinoma cells
43. Differential responses of normal, premalignant, and malignant human bronchial epithelial cells to receptor-selective retinoids
44. Expression of retinoic acid receptor γ correlates with retinoic acid sensitivity and metabolism in head and neck squamous cell carcinoma cell lines